These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2590771)

  • 21. Nicotinic ligands modulate ethanol-induced dopamine function in mice.
    Sajja RK; Dwivedi C; Rahman S
    Pharmacology; 2010; 86(3):168-73. PubMed ID: 20714207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
    Pabreza LA; Dhawan S; Kellar KJ
    Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
    Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
    Liang SD; Vizi ES
    J Pharmacol Exp Ther; 1997 Feb; 280(2):650-5. PubMed ID: 9023275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of various "nicotine-like" agents in the cat superior cervical ganglion in situ.
    Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(1):93-117. PubMed ID: 4273828
    [No Abstract]   [Full Text] [Related]  

  • 26. Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats.
    Linville DG; Williams S; Raszkiewicz JL; Arneric SP
    J Pharmacol Exp Ther; 1993 Oct; 267(1):440-8. PubMed ID: 8229773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
    Yohannes D; Procko K; Lebel LA; Fox CB; O'Neill BT
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2316-9. PubMed ID: 18356044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Crystal and molecular structure of cytisine salts].
    Niedźwiecka J; Przybył AK; Kubicki M
    Przegl Lek; 2012; 69(10):998-1003. PubMed ID: 23421078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico characterization of cytisinoids docked into an acetylcholine binding protein.
    Abin-Carriquiry JA; Zunini MP; Cassels BK; Wonnacott S; Dajas F
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3683-7. PubMed ID: 20493692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotinic receptor partial agonists alter catecholamine homeostasis and response to nicotine in PC12 cells.
    Turcanu DS; Kirtok N; Eibl C; Guendisch D; LaGamma EF; Nankova BB
    Neurosci Lett; 2012 May; 516(2):212-6. PubMed ID: 22503726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist and antagonist effects of cytisine in vivo.
    Radchenko EV; Dravolina OA; Bespalov AY
    Neuropharmacology; 2015 Aug; 95():206-14. PubMed ID: 25839895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total synthesis of (+/-)-cytisine.
    O'Neill BT; Yohannes D; Bundesmann MW; Arnold EP
    Org Lett; 2000 Dec; 2(26):4201-4. PubMed ID: 11150199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
    Fitch RW; Kaneko Y; Klaperski P; Daly JW; Seitz G; Gündisch D
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1221-4. PubMed ID: 15686946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytisine-induced behavioral activation: delineation of neuroanatomical locus of action.
    Museo E; Wise RA
    Brain Res; 1995 Jan; 670(2):257-63. PubMed ID: 7743189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some studies on cytisine and its methylated derivatives.
    Barlow RB; McLeod LJ
    Br J Pharmacol; 1969 Jan; 35(1):161-74. PubMed ID: 4387392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
    Gopalakrishnan M; Molinari EJ; Sullivan JP
    Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The exceptional hydrogen-bond properties of neutral and protonated lobeline.
    Locati A; Berthelot M; Evain M; Lebreton J; Le Questel JY; Mathé-Allainmat M; Planchat A; Renault E; Graton J
    J Phys Chem A; 2007 Jul; 111(28):6397-405. PubMed ID: 17585846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of the nitrogen substitution in three cytisine derivatives as ligands for the neuronal nAChRs: a structural and theoretical study.
    Bombieri G; Meneghetti F; Artali R; Tasso B; Canu Boido C; Sparatore F
    Chem Biodivers; 2008 Sep; 5(9):1867-78. PubMed ID: 18816516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locomotor activity in rats after administration of nicotinic agonists intracerebrally.
    Reavill C; Stolerman IP
    Br J Pharmacol; 1990 Feb; 99(2):273-8. PubMed ID: 2328395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.